Pravastatin-Associated Musculoskeletal Symptoms

Introduction to Musculoskeletal Side Effects

The American College of Cardiology notes that pravastatin can cause joint pain, though this symptom is more commonly reported as muscle pain, and in placebo-controlled trials, the incidence of these complaints is similar between pravastatin and placebo, suggesting many cases may not be drug-related 1
The American Heart Association suggests that non-specific muscle aches or joint pains are the most common complaint, typically occurring without significant elevation of muscle enzymes 1

The American College of Cardiology recommends considering bilateral involvement affecting proximal muscles as a characteristic of statin-related pain 2
The American College of Cardiology also notes that onset within weeks to months after starting pravastatin is a characteristic of statin-related pain 2
Resolution after discontinuation of the medication and recurrence with rechallenge are also indicative of statin-related pain 2

The American College of Cardiology identifies age >80 years, small body frame, frailty, multisystem disease, and polypharmacy as risk factors for developing statin-associated muscle symptoms 2
The American Heart Association notes that drug interactions, particularly with cyclosporine, clarithromycin, erythromycin, gemfibrozil, and other CYP3A4 inhibitors, increase the risk of musculoskeletal symptoms 1, 5

The American College of Cardiology recommends temporarily discontinuing pravastatin until symptoms can be evaluated 2
Checking muscle enzyme levels and evaluating for alternative causes of musculoskeletal pain is also recommended 5, 2
If symptoms resolve, rechallenging with a lower dose of pravastatin or a different statin may be considered 4, 2